| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spero Therapeutics, Inc. | Director | Common Stock | 55K | $79.8K | $1.45 | May 29, 2024 | Direct |
| PARDES BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 0 | Aug 31, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | May 29, 2024 | 1 | $0 | 4 | May 30, 2024 | Director |
| SPRO | Spero Therapeutics, Inc. | Oct 5, 2023 | 1 | $0 | 4 | Oct 10, 2023 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Aug 31, 2023 | 2 | $0 | 4 | Aug 31, 2023 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| SPRO | Spero Therapeutics, Inc. | Sep 15, 2022 | 1 | $0 | 4 | Sep 19, 2022 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Sep 14, 2022 | 1 | $0 | 4 | Sep 16, 2022 | Director |
| PRDS | PARDES BIOSCIENCES, INC. | Sep 14, 2022 | 0 | $0 | 3 | Sep 16, 2022 | Director |
| SPRO | Spero Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Director |